Business Wire

IL-PRICEFX

Share
Pricefx Closes 2020 with Significant Revenue Growth, New Customers Worldwide and a Platform Reimagined for the Future of Pricing

Pricefx , the global leader in cloud pricing software, today announced another year of tremendous growth during its fiscal year ending December, 31, 2020. Despite a global pandemic and mandatory work-from-home initiatives in every region, the company recorded 44% year-over-year growth in subscription revenue.

This week, Pricefx was named to Built In Chicago’s “Best Places to Work” list , including additional accolades for “Chicago Best Midsize Companies to Work For” and “Chicago Best Paying Companies.” In 2020, Pricefx grew its global headcount by 29% and now employs nearly 400 full time people worldwide, and is currently looking to hire more than 25 new positions in the first quarter of 2021.

“The COVID-19 pandemic forced rapid and transformational changes onto our business in 2020, but this ultimately highlighted the flexibility and resiliency of our incredible team and products,” said Marcin Cichon, Co-Founder and CEO of Pricefx. “I am both impressed by, and deeply grateful for, the passionate dedication our Pricefx family showed this year, enabling us to overcome unprecedented business circumstances to successfully raise significant additional funding, launch innovative new solutions like Lightning and VELO, acquire AI optimization company Brennus Analytics and remain on a rapid growth path with 30 new customers coming on board. I believe our future has never been brighter as I look towards the coming year.”

Market Demand and Customer Wins

In 2020, Pricefx signed 30 new enterprise customers, including Altium Packaging , PLZ Aeroscience , Stahl Holdings B.V. and Verallia Group . The company serves customers in more than 37 countries, which include some of the largest manufacturing, retailing and energy businesses in the world.

To help businesses develop strategies to quickly react to changing market dynamics and challenges as a result of COVID-19, Pricefx offered its customers free access to Sales Insights Accelerator . This Accelerator is a preconfigured, easy to deploy, highly actionable pricing analytics solution that can analyze transactional data, quickly gain visibility into pricing opportunities and flag threats.

In June, Pricefx received $65 million in Series C funding , more than double the amount raised in their previous funding round, bringing the company’s total raised to $130 million. The round was led by funds advised by Apax Digital, the growth equity team of Apax Partners, with participation from existing investor Digital+ Partners. Over the last six months of the year, the company focused the new funding on expanding global market leadership and accelerating product innovation.

Product Innovation

In May 2020, Pricefx acquired Brennus Analytics , a start-up using proprietary AI technology to provide unique optimization capabilities highly applicable to the challenges of complex B2B environments. The transaction allowed Pricefx to incorporate state-of-art AI technology into its price optimization software and bring on a team of exceptionally talented AI and data science professionals.

To that end, Pricefx launched a set of groundbreaking product enhancements in its Vesper release in November 2020. Delivering a more streamlined, powerful and agile pricing platform, the company introduced a sleek, dynamic new look for all of Pricefx’s industry-leading pricing modules with Unity UI; PriceOptimizer AI, a next-generation price optimization solution powered by transparent and predictive machine learning and multi-agent AI; and new pre-defined solution building blocks that quickly and easily incorporate best practice functionality.

Earlier in the year, Pricefx announced Lightning , the first turnkey solution to enable rapid activation of pricing excellence. Powered by Pricefx Accelerators, Lightning delivers a full suite of standard pricing analytics, management and CPQ realization tools, able to go live in six weeks or less. This was followed by a partnership with Bain & Company to launch three advanced pricing Accelerators to help Bain customers address frontline discounting, pricing leakage and promotion management.

Most recently, Pricefx introduced Velo , the industry’s first strategic large deal negotiation solution. Designed for large, complex deals, Velo maximizes profitability and leverage by combining proven strategy with innovative technology.

Awards and Accolades

In December, Tracxn included Pricefx in its Soonicorn Club of Germany which recognizes the top companies which have the potential to become Unicorns. As a Soonicorn, Pricefx has been placed amongst the leading tech startups of Germany. The rating is based on a detailed analysis by Tracxn internal sector specialist teams coupled with a combination of multiple publicly available signals such as market size, investment by marquee investors, execution excellence and future growth prospects.

Over the last 12 months, Pricefx products were also honored for innovation and customer traction. The 2020 SaaS Awards Program named Pricefx the Best SaaS for Sales and Marketing and the company took the Gold Stevie® Award for the manufacturing solution category in the 2020 International Business Awards. Pricefx was named the Bronze Stevie® Award winner in the 2020 American Business Awards for best cloud application/service.

The innovative Pricefx offering continued to garner attention from the global industry analyst community, earning them inclusion in the Gartner Magic Quadrant for CPQ for the second year in a row. Gartner included Pricefx in more than a dozen research reports, analyst notes and Hype Cycle reports, covering topics including AI and data science, pricing optimization, sales and CRM, and sales execution.

Pricefx remained in the leader quadrant on both the Pricing and Momentum G2 Grids for all four quarters of the year. The company has been reviewed by more than 50 verifed customers on the G2 platform to date. In 2020, Pricefx continued to make the Constellation ShortList ™ for Price Optimization.

Demonstrating a strong partnership with SAP, Pricefx was a 2020 SAP® Pinnacle Award finalist for SAP App Center Partner of the Year . Finalists and winners in 34 categories were chosen based on recommendations from the SAP field, customer feedback and performance indicators. Additionally, its Optimized Dynamic Pricing (ODP) solution became an SAP endorsed app, a new category of solutions from SAP’s partner ecosystem to help customers become best-run, intelligent enterprises.

Follow Pricefx

Blog: https://www.pricefx.com/site/blog/
Twitter: https://twitter.com/price_fx
LinkedIn: https://www.linkedin.com/company/price-f-x-/

About Pricefx

Established in 2011 in Germany, Pricefx is the global leader in SaaS pricing software, offering a comprehensive suite of solutions that are fast to implement, flexible to configure and customize, and friendly to learn and use. Pricefx delivers a complete price optimization and management platform based on native cloud architecture, providing industry leading time to value and total cost of ownership advantages to customers. Their innovative solution works for both B2B and B2C enterprises of any size, in any industry, in any part of the world. Pricefx’s business model is entirely based on the satisfaction and loyalty of its customers. Today, Pricefx delivers Passion for Pricing to hundreds of global customers in more than 40 countries worldwide. For more information, please visit www.pricefx.com .

###

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse

Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release

Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye